GSK Buys Back Own Shares
Ticker: GLAXF · Form: 6-K · Filed: Jul 11, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Jul 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-buyback, stock-repurchase
TL;DR
GSK is buying back its own stock via Merrill Lynch.
AI Summary
GSK plc announced on July 11, 2025, that it purchased a number of its own ordinary shares through its corporate stockbroker, Merrill Lynch International. The filing does not specify the exact number of shares or the total dollar amount of the transaction.
Why It Matters
Share buybacks can signal management's confidence in the company's valuation and potentially increase earnings per share.
Risk Assessment
Risk Level: low — This is a routine disclosure of share repurchases, which is common for publicly traded companies.
Key Players & Entities
- GSK plc (company) — Filer of the report
- Merrill Lynch International (company) — Corporate stockbroker executing share purchases
- July 11, 2025 (date) — Date of the announcement and transaction
FAQ
What was the total number of GSK ordinary shares purchased?
The filing states that GSK purchased 'the following number of the Company's ordinary shares' but does not specify the exact quantity in the provided text.
What was the total dollar amount spent on the share repurchases?
The filing does not disclose the total dollar amount of the share repurchases.
Who acted as GSK's corporate stockbroker for these transactions?
Merrill Lynch International acted as GSK's corporate stockbroker.
On what date did GSK announce these share repurchases?
GSK announced these share repurchases on July 11, 2025.
What is the par value of GSK's ordinary shares?
The ordinary shares have a par value of 31 1/4 pence each.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 11, 2025 regarding GSK plc (GLAXF).